RecruitingNot ApplicableNCT06857331

Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients

Optimization of Perioperative Analgesia With Erector Spinae Plane Block During Major Abdominal Surgeries in Patients With Impaired Liver Function

Sponsor

Bogomolets National Medical University

Enrollment

50 participants

Start Date

May 5, 2024

Study Type

INTERVENTIONAL

Conditions

Liver Transplant Erector Spina Plan Block

Summary

The goal of this clinical trial is to learn if ESP block is safe and effective for perioperative analgesia in patients undergoing liver transplant. The main question it aims to answer are Is ESP block safe and has a minimum side effects, like hematoma? Is it effective for perioperative analgesia? Researchers will compare the results to a group of patients who underwent liver transplants without any regional anaesthesia techniques. Participants will receive bilateral thoracic ESP block on the day of the transplantation with a subsequent bilateral catheterization.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Erector Spinae Plane Block using 0.2% ropivacaine for people with erector spina plan block and liver transplant. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREErector Spinae Plane Block using 0.2% ropivacaine

Bilateral thoracic ESP block on the day of the transplantation with a subsequent catheterization will be suggested for the patients. In case of their written consent for the participation in the study this procedure will be performed on the day of the operation. 0.2% ropivacaine is going to be used throughout all the perioperative period.